Litcius/Paper detail

Challenges and opportunities in drug development for nonalcoholic steatohepatitis

Matthias Ocker

2020European Journal of Pharmacology14 citationsDOI

Topics & Concepts

Nonalcoholic fatty liver diseaseNonalcoholic steatohepatitisMedicineDrug developmentFibrosisDiseaseClinical trialLiver diseaseBioinformaticsStage (stratigraphy)DrugInternal medicineChronic liver diseaseFatty liverIntensive care medicinePharmacologyCirrhosisBiologyPaleontologyLiver Disease Diagnosis and TreatmentEndoplasmic Reticulum Stress and DiseaseHepatitis C virus research
Challenges and opportunities in drug development for nonalcoholic steatohepatitis | Litcius